8. Tumour Microenvironment Flashcards
(130 cards)
1
Q
why is there variability in cancer survival rates? (4)
A
- some organs more/less necessary
- how easily it is detected (location, screening)
- patient variability
- molecular characteristics of tumour, pathways
2
Q
5 things that affect heterogeneity of cancer
A
- genetic
- epigenetic
- phenotypic
- microenvironment
- clinical response
3
Q
4 types of cancer
A
- carcinoma
- sarcoma
- lymphoma, leukemia
- brain cancer
4
Q
what type of cells are involved in carcinoma?
A
epithelial cells
5
Q
what type of tissue is involved sarcoma?
A
supporting tissue (bone, cartilage, fat, connective tissue, muscle)
6
Q
what type of cells are involved in lymphoma/leukemia?
A
cells of blood and lymphatic origin
7
Q
3 main characteristics of cancer
A
- loss of growth control
- local invasion
- altered tissue organization
8
Q
quantitative element of loss of growth control
A
number of cells
9
Q
qualitative element of loss of growth control
A
differentiation and orientation of cells
10
Q
3 aspects of somatic mutation theory
A
- mutations are necessary for cancer to arise
- mutations cause uncontrolled proliferation
- cancer is irreversible
11
Q
what is assumed if mutations cause uncontrolled proliferation?
A
if mutations cause uncontrolled proliferation, this assumes the default state of a cell is quiescence (i.e. dormant/inactive)
12
Q
why does SMT say that cancer is irreversible?
A
if solely caused by mutations, mutations cannot be undone therefore cancer is irreversible
13
Q
what does SMT imply about cancer overall?
A
SMT implies that cancer is a cellular disease
14
Q
development of cancer via SMT (7 steps)
A
- DNA damage
- mutation
- self-sufficient growth
- resistance to apoptosis
- invasion
- tumour
- metastasis
15
Q
are mutations actually sufficient for cancer development? evidence?
A
mutations are NOT sufficient for cancer development
many mutations are found in normal skin, so must be another factor contributing to cancer
16
Q
describe normal proliferation of epithelial cells
A
epithelial cells normally highly proliferative
- high turnover to eliminate damaged cells
- proliferative in specific zones
17
Q
what controls proliferation of epithelial cells normally?
A
stem and progenitor cells control proliferation of epithelial cells
18
Q
normally, epithelial cells are proliferative in specific zones but how does this change in tumours?
A
in tumours, these zones get larger
19
Q
what does carcinoma develop from?
A
pre-malignant stages
20
Q
how long can it take carcinomas to develop?
A
years to decades
21
Q
describe the experiment to determine whether mutations are sufficient for cancer development in any cell
A
introduce oncogenes and tumour suppressors in diff cell populations –> not all will form tumours
22
Q
describe the experiment with Prom1+ cells
A
Prom1+ usually have big generative ability over time
but not all Prom1+ cells were equally susceptible
- Quiescent cells were less vulnerable
- Generative cells were more vulnerable
23
Q
what does damage-induced stem cell activation lead to?
A
damage-induced stem cell activation sensitizes cells to promote tumour formation
24
Q
with the results from the experiment looking at whether mutations alone are sufficient for cancer development, what does this tell us about tumour formation?
A
events outside of epithelium/tissue repair responses can sensitize tissues to form a tumour
25
how is inflammation related to cancer incidence?
inflammation associated with INCREASED cancer incidence
26
how does inflammation increase cancer incidence?
1. stromal cells accumulate and activate --> PRO-TUMOURIGENIC
2. changes microenvironment
27
what is the correlation btwn impaired immunity and cancer
incidence of lung, GI, reproductive, and skin cancers is higher in IMMUNOSUPPRESSED organ transplant patients
but incidence of breast cancer is lower
THEREFORE, immune responses are highly variable btwn cancer types and people --> no definitive link
28
is cancer irreversible?
some evidence of tumour regression
29
9 mechanisms that could cause tumour regression
1. silencing oncogenes/activating tumour suppressors
2. epigenetic mutations
3. tumour inhibition by growth factors, cytokines
4. induction of differentiation
5. hormonal mediation
6. elimination of carcinogen
7. tumour necrosis or apoptosis
8. angiogenesis inhibition
9. immune mediation
30
what cannot cause tumour regression?
mutations "un-mutating"
31
what is the theory after SMT?
Tissue Organization Field Theory (TOFT)
32
3 components of TOFT
1. Mutations lead to cancer by disrupting morphostats
2. mutations that induce proliferation are not needed for carcinogenesis
3. genetic instability is only a BYPRODUCT of carcinogenesis
33
what does it mean for cancer to be caused by disruption of morphostats?
mutations don't change proliferation, just disrupt the homeostasis of tissue to affect growth control
34
SMT vs TOFT
These theories are opposite and incompatible
35
what does TOFT imply about cells?
implies cells are inherently proliferative
36
what does TOFT imply about where carcinogenesis occurs?
implies carcinogenesis occurs at the TISSUE level, not cellular
37
what does TOFT imply about reversibility/irreversibility of carcinogenesis?
TOFT states that carcinogenesis is REVERSIBLE
38
describe the epithelial defense against cancer
NORMAL epithelial cells have an intrinsic ability to suppress/eliminate adjacent tumour cells
39
how do normal epithelial cells suppress tumour epithelial cells? (5)
1. competition btwn more/less fit cells
2. non-cell autonomous functions
3. apical extrusion
4. apoptosis
5. senescence
40
how is apical extrusion initiated?
cells can distinguish mechanical differences btwn its neighbours
41
3 steps of apical extrusion
1. altered oncogenes = altered cytoskeleton
2. normal cells can detect the stiffness of mutant cells
3. normal cells can contract and SQUEEZE the stiff/mutant cells out of the epithelium into lumen or cause APOPTOSIS
42
what is basal extrusion?
tumour cells pushed further into the tissue, out of the epithelium until it reaches stroma --> cells stay in contact with ECM so it can stay alive
43
describe the competition in apical extrusion. what does this explain?
mutant cell is the LOSER, basal cell is the WINNER --> therefore cancer is rare
44
what regulates the epithelial defense?
regulated by micro/systemic environment
45
how does the systemic environment regulate epithelial defense?
obese --> less efficient at removing tumour cells
46
what happens to tumour microenvironment in obese tissue
- aligned collagen --> more stiff
- increased inflammation
- cannot extrude mutant cells --> stay in epithelium
47
what does competition btwn normal and mutant cells lead to?
competition leads to senescence of damaged cells
48
what is competition controlled by?
competition is controlled by p53
49
how does p53 mediate competition?
based on relative p53 levels --> low p53 cells WIN and suppress cells with high p53
50
how is p53-mediated competition related to p53-mediated DNA damage?
p53-mediated competition is INDEPENDENT of p53-mediated DNA damage
51
what do the breast duct and myoepithelium do?
breast duct produces milk, myoepithelium is contractile to squeeze milk
52
what happens in stage 0 of breast cancer? (3)
- basic structure of ducts are arranged in pre-invasive lesions
- ducts maintain some organization with myoepithelium
- ducts become more solid
53
why do breast ducts become more solid in breast cancer?
cells extruded to lumen may be surviving, making it more solid
54
what occurs in stage 1-3 of breast cancer?
myoepithelium starts to break down, allowing for invasion
55
what is the main indicator of whether breast cancer is invasive or not?
if myoepithelium breaks down --> INVASIVE
56
how do myoepithelial cells prevent dissemination/invasion? (3 steps)
1. tumour cells start to invade
2. myoepithelium captures/restrains/pulls tumour cells back in
3. myoepithelium prevents invasion even once tumour cells have unattached
57
why does the prevention of dissemination by myoepithelium show that the tumour microenvironment is important?
normal tissue in the surroundings can restrain tumour properties and characteristics
58
are the hallmarks of cancer reliant on mutant cells or microenvironment? what is the significance?
most of the hallmarks of cancer are INDEPENDENT of mutant cells and rely on interactions with microenvironment
therefore, more than just the mutant cell is involved
59
what kinds of cells are found in tumours? (general types and 6 specific types)
cells with pro AND anti-tumourigenic properties
1. malignant cancer cells
2. immune cells
3. fibroblasts
4. adipocytes
5. vasculature
6. tissue-specific cells
60
how can we predict patient outcome in relation to stromal micronevironment
isolate stromal regions --> look at gene expression patterns associated with patient outcomes
61
do normal tissues have microenvironment?
yes, but modified with tumour
62
describe co-evolution of tumour and microenvironment
as tumour evolves, microenvironment also evolves
63
how does microenvironment change with diff tumours?
tumours have diff compositions, proportions, and activation states of stroma at diff times
stroma supports metabolic requirements of tumour
64
describe the microenvironment in metastatic disease
cancer cells disseminate to other areas where the microenvironment hasn't evolved to support the cells --> cells cannot be supported in the same way
65
what are cancer associated fibroblasts (CAF)?
fibroblasts that have been reprogrammed within the tumour microenvironment to promote tumour progression accomplish hallmarks of cancer
66
2 things that CAFs indicate
1. heterogeneity of stroma
2. tumour and its microenvironment have high plasticity
67
where do CAFs come from?
can come from anything --> many mechanisms can produce them
68
are CAFs one cell type?
no, it is just a term to broadly describe many cell types with diff functions
69
when and how do CAFs interact with cancer cells?
during INVASION
CAFs directly ASSOCIATE WITH and LEAD cancer cells
70
2 ways that CAFs help cancer cells invade?
1. CAF remodels ECM
2. CAF has dynamic adhesions with cancer cells to pull/drag them
71
what is one of the main products from fibroblasts?
collagen deposition
72
why are tumours typically stiffer than normal tissue?
fibroblasts induce collagen deposition
73
is collagen deposition/stiffness uniform for a tumour?
no, not fully uniform throughout tumour
74
2 consequences of increased stiffness of tumour cells
1. modulates growth properties
2. allows tumour cells to be more motile
75
experiment to determine that increased stiffness allows tumour cells to be more motile
put normal cells and tumour cells on matrices with diff stiffness
- invasion on stiff matrix
- no invasion on soft matrix
76
how is the recognition of stiffness by normal cells related to mutation type?
INDEPENDENT of mutation type
77
how does oxygen affect tumour progression? (4)
HYPOXIA impacts:
1. vascularization
2. treatment resistance
3. EMT
4. metastasis
78
why are tumours not so affected by hypoxia?
tumour cells are good at adapting to stress --> to promote survival
79
what is one of the most abundant cell types?
macrophages
80
2 states of macrophages
1. tissue-resident
2. M1/M2
81
where do tissue-resident macrophages come from?
deposited in tissue during embryonic development
82
where do tissue-resident macrophages reside?
in diff compartments: stromal, epithelial
83
role of tissue-resident macrophages
suppress/engulf apoptotic cells
84
why do tissue-resident macrophages suppress/engulf apoptotic cells
apoptotic cells secrete factors that induce inflammation but want to PREVENT inflammation
85
M1 vs M2 macrophages
M1 = anti-tumour
M2 = pro-tumour
86
what determines whether M1 or M2 macrophage is activated?
naturally anti-tumourigenic but integrates multiple signals from microenvironment to control activation (but actually more complex, less binary)
87
what do tumour-associated macrophages do?
allow for tumour cell proliferation and migration
88
4 steps in the function of TAMs
1. TAM secretes EGF
2. EGF activates EGFR on tumour cells
3. upregulates VEGF/VEGFR signaling in surrounding tumour cells
4. tumour cell proliferation and migration
89
in addition to proliferation and migration, what do TAMs do?
stimulate invasion and promote survival disseminated cells
90
how do TAMs promote survival of disseminated cells? (3 steps)
1. tumour cells are shed into abdominal cavity
2. normally, they will die BUT macrophages associate and activate program to bind epithelial cells
3. allows shed cells to interact with peritoneal cavity and cause disease
91
how do macrophages stimulate invasion and metastasis? (3 steps)
1. cell recruits macrophages with CCL2
2. macrophage responds with Wnt1 as pro-survival factor
3. allows reciprocal signaling btwn epithelial cell and macrophage so epithelial cell can be supported upon dissemination
92
how do macrophages affect ECM? what is the effect of this?
ECM is organized parallel to the edge of the tumour so cells usually travel along the ECM
- macrophages remodel ECM to direct the cell AWAY from the tumour for metastasis
93
what is immune surveillance?
immune system can recognize tumour cells and modulate tumour growth
94
immune response in normal cells vs transformed cells
normal cells usually NOT immune-responsive
transformed cells express tumour-associated antigens that can be recognized by the immune system
95
what can tumour-associated antigens be?
mutant proteins, junk material, etc.
96
what happens when immune cells recognize the tumour associated antigens?
present antigens to T cells for elimination
97
describe the equilibrium that is reached in immune surveillance
reaches equilibrium where
A. tumour cells have adapted
B. cells with strongest tumour antigens have been eliminated
98
describe the tumour at equilibrium
tumour is neither regressing nor progressing
99
can the immune system/tumour leave equilibrium?
yes --> immune system is modified/edited to allow tumour growth (escape phase)
100
3 stages of immunoediting
1. eilimination
2. equilibrium
3. escape
101
what happens in the first phase of immunoediting?
ELIMINATION --> vulnerable tumour cells are cleared by the immune system, resistant tumour cells survive
102
what causes the equilibrium phase of immunoediting?
EQUILIBRIUM --> driven by strong selective pressure from adaptive immune system + T cells
103
what causes the escape phase of immunoediting?
global IMMUNOSUPPRESSIVE state with anti-inflammatory cytokines
104
how can we use immunoediting as a way to find treatments?
find therapeutics that make the immunoediting process stay in the equilibrium phase
105
describe T cell activity in tumour cells
in the tumour, they follow the same biological and physiological rules as normal but mechanisms are induced to PREVENT OVER-ACTIVATION --> leads to T cell exhaustion
106
what happens with T cell exhaustion?
T cells become less responsive to antigens and less efficient
107
how is T cell activity suppressed in cancer?
1. immune checkpoints induced by cancer and stromal cells will suppress T cell activity
2. neutrophils and Treg with suppressive functions in tumour microenvironment
108
what is an immune hot tumour?
immune cells are active INSIDE the tumour
109
what is an immune cold tumour?
immune cells are active on the PERIPHERY of the tumour
110
how do immune hot and immune cold tumours change the cancer?
change the response and treatment
as well, varies throughout the tumour
111
why does immune hot and immune cold change throughout tumour?
diverse immune-epithelial interactions change hot/cold
112
benefit of targeting the tumour microenvironment
stroma is genetically stable compared to tumour cells --> less likely to become resistant
113
what is the problem with targeting the tumour microenvironment and example?
may deplete stromal cells required for anti-tumour function
ex. angiogenesis inhibitors may not work bc they block the anti-tumourigenic effects of the microenvironment
114
goal of immunotherapy
improve or induce immunological surveillance recognition and destruction of cancer cells --> i.e. RE-EDUCATE immune system
115
5 immunotherapeutic approaches
1. adoptive cell transfer
2. checkpoint inhibitor
3. MAb
4. cancer vaccines
5. cytokines
116
describe adoptive cell transfer
take T cells from patient, re-engineer to express receptor for tumour antigen and give back to patient
117
result of adoptive cell transfer?
increases proliferation and activity of T cells against tumour cells with the antigen
118
what was the first adoptive cell transfer treatment?
recognize CD19 on B cells for lymphoblastic leukemia
119
what is the purpose of immune checkpoints?
prevents over-activation of immune system
120
what do immune checkpoint blockers do?
allows immune system to target cancer cells
121
CTLA4 checkpoint inhibitor
normally, CTLA4 inhibits T cell activity by outcompeting co-stimulatory CD28 for CD80/CD86
use anti-CTLA4 to increase T cell activity
122
PDL1 checkpoint inhibitor
normally, PDL1 is expressed on tumour cells to inhibit T cell activity
use anti-CPDL or anti-PDL1 to increase T cell activity
123
where are immune checkpoint inhibitors most effective?
effective in immune HOT tumour where immune cells are in contact with epithelial cells
124
describe MAb
use antibodies against markers on tumour cells to remove tumour cells
125
describe destruction of tumours with antibodies
increase the association btwn tumour cell and T cell with bispecific antibodies
126
example of destruction of tumours with antibodies in pancreatic cancer
pancreatic cancer cells express EpCAM on their surface
Ab recognizes EpCAM on cancer cell and CD3 on T cell --> brings cancer cell in direct contact with T cell
127
describe cancer vaccines
vaccinate against cell surface markers on cancer cells
128
how can we re-educate the stroma? explain
reprogram TAMs
1. TAMs normally require CSF-1 for differentiation and survival
2. use CSF-1 INHIBITOR to restore TAMs to anti-tumour activity
129
why is re-educating the stroma helpful?
can be used prophylactically to prevent macrophages from become pro-tumour
130
issue with immunotherapy
immune hot tumours are more responsive --> must turn cold tumours into hot tumours in combo with cytotoxic therapies
